Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments
Recruiting · NCT06777758 · Interventional (participants receive a specific treatment) · Lead sponsor: Kaohsiung Veterans General Hospital.
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.
Who can take part
Age range
20 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Subjects are between 20-80 years old.
- Anesthesiologists rated ASA as between I and III.
- Patients undergoing upper gastrointestinal endoscopic examination or therapy.
Exclusion criteria
- Allergy to Propofol, Remimazolam, or opioid medications.
- Emergency surgery.
- Pregnancy.
- History of malignant hyperthermia.
- Impaired liver or kidney function.
- Airway difficulties due to pharyngeal tumors.
- Refusal to participate.
Where it is running
1 location listed.
- Kaohsiung Veterans General Hospital - Kaohsiung City, Taiwan